Docoh
Loading...

Mon. 11 Oct 2021, 7:02am ETBenzinga
In: News, Price Target, Initiation, Analyst Ratings
Guggenheim analyst Chris Pasquale initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy rating and announces Price Target of $45.